Brian Wasko
Permanent URI for this collectionhttps://hdl.handle.net/10657.1/2515
Dr. Brian Wasko is an Assistant Professor at University of Houston-Clear Lake. Dr. Wasko's research interests include Biology of Aging, Cellular pH and Metal Homeostasis, Basic Molecular and Cellular Biology.
Browse
Browsing Brian Wasko by Subject "Autophagy / drug effects. Blotting, Western Cell Line Coloring Agents DNA / biosynthesis DNA / genetics Diphosphonates / pharmacology* Enzyme Inhibitors / pharmacology* Farnesyltranstransferase / antagonists & inhibitors* Humans Imidazoles / pharmacology Immunoprecipitation Octoxynol Polyethylene Glycols Polyisoprenyl Phosphates / biosynthesis Polyisoprenyl Phosphates / metabolism* Protein Prenylation drug effects, Tetrazolium Salts, Thiazoles, Zoledronic Acid"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
Item Bisphosphonates Induce Autophagy by Depleting Geranylgeranyl Diphosphate(J Pharmacol Exp Ther., 2011) Wasko, BrianMultiple studies have implicated the depletion of isoprenoid biosynthetic pathway intermediates in the induction of autophagy. However, the exact mechanism by which isoprenoid biosynthesis inhibitors induce autophagy has not been well established. We hypothesized that inhibition of farnesyl diphosphate synthase (FDPS) and geranylgeranyl diphosphate synthase (GGDPS) by bisphosphonates would induce autophagy by depleting cellular geranylgeranyl diphosphate (GGPP) and impairing protein geranylgeranylation. Herein, we show that an inhibitor of FDPS (zoledronate) and an inhibitor of GGDPS (digeranyl bisphosphonate, DGBP) induce autophagy in PC3 prostate cancer and MDA-MB-231 breast cancer cells as measured by the accumulation of the autophagic marker LC3-II. Treatment of cells with lysosomal protease inhibitors [(2S,3S)-trans-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester (E-64d) and pepstatin A] in combination with zoledronate or digeranyl bisphosphate further enhances the formation of LC3-II, indicating that these compounds induce autophagic flux. It is noteworthy that the addition of exogenous GGPP prevented the accumulation of LC3-II and impairment of Rab6 (a GGTase II substrate) geranylgeranylation by isoprenoid pathway inhibitors (lovastatin), zoledronate, and DGBP). However, exogenous GGPP did not restore isoprenoid pathway inhibitor-induced impairment of Rap1a (a GGTase 1 substrate) geranylgeranylation. In addition, specific inhibitors of farnesyl transferase and geranylgeranyl transferase I are unable to induce autophagy in our system. Furthermore, the addition of bafilomycin A1 (an inhibitor of autophagy processing) enhancer the antiproliferative effects of digeranyl bisphosphonate. These results are the first to demonstrate that bisphosphonates induce autophagy. Our study suggests that induction of autophagy in PC3 cells with these agents is probably dependent upon impairment of geranylgeranylation of GGTase II substrates.